Alivus Life Sciences to meet Kosh Wealth in Mumbai

Alivus Life Sciences Limited has scheduled an in-person, one-on-one meeting with Kosh Wealth Management for December 30, 2025, in Mumbai. The company, which recently changed its name from Glenmark Life Sciences Limited, will engage with the investor to provide updates and discuss company performance. This disclosure aligns with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The meeting details were communicated to BSE Ltd. and the National Stock Exchange of India Ltd. Rudalf Corriea, company secretary and compliance officer, signed the official intimation on December 24, 2025. The company noted that the schedule and mode of the meeting might change due to unforeseen circumstances.

This engagement underscores Alivus Life Sciences' commitment to transparency and regular communication with its investor base, ensuring compliance with regulatory mandates for disclosing significant corporate events.